MAGI

MAGI (often referred to as MAGI Lab or MAGI Group) is an Italian biotechnology organization dedicated to the diagnosis and treatment of rare genetic diseases, with a specialized focus on ophthalmic and vascular conditions. The company operates as a network of non-profit and for-profit entities that combine genetic diagnostic services with the development of novel dietary supplements and pharmaceutical therapies. MAGI is particularly recognized for its research into lipedema and lymphedema, as well as inherited retinal degenerations. Their business model integrates clinical research, genetic counseling, and the commercialization of specific formulations designed to manage chronic conditions associated with genetic defects.